Specific knockout of notch-1 attenuates non-alcoholic fatty liver disease by promoting SHP2 phosphorylation

Qian Gao1, Yonggang Lu2, Weiling Zhou1

  • 1Department of Endocrine and Metabolic Diseases, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050000, China.

Aging
|December 14, 2023
PubMed
Abstract

Insights

Specific knockout of Notch-1 signaling in macrophages reduces non-alcoholic fatty liver disease (NAFLD) by decreasing liver inflammation and lipid deposition. This occurs through promoting SHP2 phosphorylation, offering a potential therapeutic target for NAFLD.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Immunology

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is a growing global health concern.
  • The role of Notch-1 signaling in the pathogenesis of NAFLD remains incompletely understood.

Purpose of the Study:

  • To investigate the impact of Notch-1 signaling in macrophages on NAFLD.
  • To elucidate the molecular mechanisms underlying Notch-1's effect on NAFLD.

Main Methods:

  • Utilized a mouse model with specific knockout of Notch-1 in macrophages (Notch-1MAC-KO).
  • Assessed liver lipid deposition using oil red O staining.
  • Analyzed protein expression in macrophages and exosomes via Western blotting, including key markers for lipid metabolism, inflammation, and signaling pathways (e.g., SREBP1C, IL-1β, Notch-1, p-SHP2).
  • Investigated the effects of SHP2 inhibitors (PHPS1 and Relaxin).

Main Results:

  • Notch-1 knockout in macrophages significantly reduced lipid deposition and inflammation in NAFLD mice.
  • Macrophage-derived exosomal expressions of ALIX, CD9, IL-1β, and SREBP1C were decreased in Notch-1MAC-KO mice.
  • Knockout of Notch-1 in macrophages led to decreased expression of SREBP1C, SREBP2, LXR, IL-1β, IL-18, NOX2, NOX4, and p-PI3K, alongside increased p-SHP2 expression.
  • Treatment with SHP2 inhibitors mimicked the protective effects of Notch-1 knockout, normalizing protein expression levels.

Conclusions:

  • Specific knockout of Notch-1 in macrophages attenuates NAFLD.
  • This attenuation is mediated by reduced liver inflammation and lipid deposition.
  • The mechanism involves the promotion of SHP2 phosphorylation, highlighting a potential therapeutic strategy for NAFLD.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K